ContraFect (NASDAQ:CFRX – Get Rating) posted its earnings results on Thursday. The biotechnology company reported ($0.11) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.26) by $0.15, Fidelity Earnings reports. ContraFect stock opened at $3.84 on Friday. The business’s fifty day simple moving average is $3.09 and its two-hundred […]